NCT01761929View on ClinicalTrials.gov

5 Fraction Stereotactic Body Radiation Therapy for Oligometastases Regimen, for Extra-Cranial Oligometastases

PHASE2CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

March 7, 2013

Primary Completion Date

February 8, 2023

Study Completion Date

February 8, 2023

Conditions
Solid Tumors With Oligometastatic Spread
Interventions
RADIATION

Radiation: 50Gy in 5 fr (max) to 25 Gy in 5 fr (min). Dose adapted to deliver the highest dose level while respecting normal tissue tolerance

All patients will be treated with SBRT 1-2 weeks after radiotherapy planning scans. Therapy will be given once daily, over 5 consecutive working days according to standard practice.

Trial Locations (1)

M5G 2M9

University Health Network, Princess Margaret Cancer Center, Toronto

All Listed Sponsors
collaborator

Princess Margaret Hospital, Canada

OTHER

lead

University Health Network, Toronto

OTHER

NCT01761929 - 5 Fraction Stereotactic Body Radiation Therapy for Oligometastases Regimen, for Extra-Cranial Oligometastases | Biotech Hunter | Biotech Hunter